CHEYENNE UTT: Open Payments
NPI 1134880339 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 110 payments from 12 companies in 2025. Trend: 2023 $741 · 2024 $1,512 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $476 |
| Neurocrine BioSciences, Inc. | 12 | $214 |
| Vanda Pharmaceuticals Inc. | 10 | $185 |
| E.R. Squibb & Sons, L.L.C. | 11 | $168 |
| Otsuka America Pharmaceutical, Inc. | 10 | $135 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| Lundbeck LLC | 3 | $61 |
| HARMONY BIOSCIENCES LLC | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Alkermes, Inc. | 2 | $43 |
Products named: VRAYLAR, INGREZZA, HETLIOZ, COBENFY, REXULTI, SPRAVATO, ABILIFY ASIMTUFII, WAKIX.
Industry payments across NC — which companies pay providers there.
